Company
Headquarters: Guangzhou, China
Employees: 1,252
CN¥1.86 Billion
CNY as of Jan. 1, 2025
US$255.0 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells laboratory consumable products. The company's principal products include laboratory consumables, such as pipettes, tissue culture products, centrifuge tubes, filtration products etc.; and analyzers, lab equipment, reagents, gloves, and other products. It provides its products to approximately 50 countries, including the United States, Japan, Canada, Germany, Australia, and South Korea. The company was founded in 2001 and is based in Guangzhou, China.
Guangzhou Jet Bio-Filtration Co. Ltd has the following listings and related stock indices.
Stock: SSE: 688026 wb_incandescent